A multi-well filter plate equipped with a membrane that can efficiently bind DNA and RNA from multiple samples.
The AcroPrep 96-well filter plate features a silica-based quartz glass fiber media that efficiently captures DNA and RNA for nucleic acid binding (NAB). This media can be used to purify plasmid DNA from bacteria or genomic DNA and total RNA from cell culture samples. Therefore, it can be utilized for a wide range of applications with a single plate. This filter plate has a structure with longer tips at the bottom of the wells, minimizing sample leakage. This property reduces the risk of cross-contamination when removing the filter plate from the receiver plate. To reduce costs, Cytiva's NAB plates can be used in conjunction with commercially available reagents to prepare genomic DNA or RNA, achieving quality and yield that is equal to or greater than that of commercial kits.
Inquire About This Product
basic information
Nucleic acid binding type filter plates that can be used for DNA and RNA purification ■ 96-well filter plate, 350 µL DNA binding (borosilicate glass) ■ 96-well filter plate, 1 mL DNA binding (borosilicate glass, long type tip) Glass fiber (1 µm)
Price information
For inquiries regarding delivery dates and prices, please use the inquiry form or the contact button.
Delivery Time
Applications/Examples of results
Purification of plasmid DNA ■ Restriction digestion ■ Cloning ■ Sanger sequencing Genome purification ■ PCR ■ Real-time PCR ■ Next-generation sequencing (NGS) Total RNA purification ■ Real-time quantitative PCR ■ Microarray ■ cDNA library construction ■ Northern blot analysis
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
